Dr. Reddy’s Set For June U.S. Launch Of Generic Of Pfizer’s Lipitor
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy’s Laboratories said it expects to be ready to launch its generic version of the world’s best-selling drug, Pfizer’s Lipitor (atorvastatin) for controlling cholesterol, in the U.S. when Ranbaxy Laboratories’ exclusive right ends in June.